Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

KIROPRAKTISK KLINIK SØNDERSØ ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.5%   Bankruptcy risk   6.5% 8.0% 16.0% 10.7% 15.1% 10.5% 21.6% 21.2%   Credit score (0-100)   38 30 10 22 12 23 4 5   Credit rating   BBB BB BB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,516 1,198 952 1,048 1,275 1,133 0.0 0.0   EBITDA   548 223 257 103 318 276 0.0 0.0   EBIT   517 217 257 103 318 276 0.0 0.0   Pre-tax profit (PTP)   499.0 188.0 251.7 97.2 307.5 276.9 0.0 0.0   Net earnings   389.0 146.7 196.3 75.6 243.0 215.8 0.0 0.0   Pre-tax profit without non-rec. items   499 188 252 97.2 308 277 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Tangible assets total   5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   580 277 136 211 209 341 16.3 16.3   Interest-bearing liabilities   320 85.3 0.0 4.7 0.0 50.3 0.0 0.0   Balance sheet total (assets)   1,203 703 359 420 454 693 16.3 16.3   Net Debt   -641 -264 -115 -143 -52.6 47.5 -16.3 -16.3     See the entire balance sheet 1000.0 Volume  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,516 1,198 952 1,048 1,275 1,133 0.0 0.0   Gross profit growth   37.3% -20.9% -20.6% 10.1% 21.7% -11.1% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,203 703 359 420 454 693 16 16   Balance sheet change%   46.9% -41.5% -49.0% 17.0% 8.1% 52.8% -97.7% 0.0%   Added value   548.0 223.0 256.8 103.0 317.8 275.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -62 -11 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   34.1% 18.1% 27.0% 9.8% 24.9% 24.3% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   51.1% 22.8% 48.4% 26.5% 73.5% 49.7% 0.0% 0.0%   ROI %   69.3% 34.4% 103.1% 58.7% 150.9% 94.9% 0.0% 0.0%   ROE %   66.4% 34.2% 95.2% 43.6% 115.5% 78.4% 0.0% 0.0%   1000.0 Solidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Equity ratio %   48.2% 39.4% 37.8% 50.3% 46.1% 49.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -117.0% -118.2% -44.8% -139.1% -16.5% 17.2% 0.0% 0.0%   Gearing %   55.2% 30.8% 0.0% 2.2% 0.0% 14.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   11.3% 14.5% 11.8% 257.8% 576.6% 33.1% 0.0% 0.0%   1000.0 Liquidity  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Quick Ratio   1.9 1.6 1.9 2.2 2.4 2.1 0.0 0.0   Current Ratio   1.9 1.6 1.9 2.2 2.4 2.1 0.0 0.0   Cash and cash equivalent   961.0 349.0 114.9 148.0 52.6 2.8 0.0 0.0   1000.0 Capital use efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   575.0 276.7 174.2 228.0 267.0 367.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/9 2020 2020/9 2021 2021/9 2022 2022/9 2023 2023/9 2024 2024/9 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   274 111 128 52 159 138 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   274 111 128 52 159 138 0 0   EBIT / employee   259 109 128 52 159 138 0 0   Net earnings / employee   195 73 98 38 122 108 0 0